CS-PEI/Beclin-siRNA Downregulate Multidrug Resistance Proteins and Increase Paclitaxel Therapeutic Efficacy against NSCLC
Paclitaxel (PTX) is a widely used chemotherapy drug; however, frequent use causes multidrug resistance (MDR), which limits the utility of PTX against advanced non-small-cell lung cancer (NSCLC). PTX-resistant subline (NCI-H23-TXR) was established in vitro by exposing NCI-H23 cells to gradually incre...
Main Authors: | Wangta Liu, Yu-Lun Lo, Chin Hsu, Yi-Ting Wu, Zi-Xian Liao, Wen-Jeng Wu, Yi-Jou Chen, Chieh Kao, Chien-Chih Chiu, Li-Fang Wang |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2019-09-01
|
Series: | Molecular Therapy: Nucleic Acids |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2162253119301805 |
Similar Items
-
miR-17-5p downregulation contributes to paclitaxel resistance of lung cancer cells through altering beclin1 expression.
by: Abhisek Chatterjee, et al.
Published: (2014-01-01) -
Targeted CRM197-PEG-PEI/siRNA Complexes for Therapeutic RNAi in Glioblastoma
by: Achim Aigner, et al.
Published: (2011-12-01) -
Intranasal drug delivery of small interfering RNA targeting Beclin1 encapsulated with polyethylenimine (PEI) in mouse brain to achieve HIV attenuation
by: Myosotys Rodriguez, et al.
Published: (2017-05-01) -
Fluorinated PEG-PEI Coated Magnetic Nanoparticles for siRNA Delivery and CXCR4 Knockdown
by: Yixiang Cao, et al.
Published: (2022-05-01) -
Voltage Preconditioning Allows Modulated Gene Expression in Neurons Using PEI-complexed siRNA
by: Arati Sridharan, et al.
Published: (2013-01-01)